Alembic Pharmaceuticals Limited — Updates, 26-06-2026: Press Release
26-06-2026 | 07:10 pm
26-06-2026 | 07:10 pm
Alembic Pharma secured USFDA final approval for Dapsone Gel, 5%, indicated for acne vulgaris. This approval enhances its US product portfolio, paving the way for market entry and potential revenue growth.
No comments yet. Be the first to comment!
